| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2548 |
| Trial ID | NCT04684472 |
| Disease | Leukemia | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Modified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell Malignancies |
| Year | 2020 |
| Country | China |
| Company sponsor | Liqun Zou |
| Other ID(s) | MCART-003 |
| Cohort 1 | |||||||
|
|||||||